Methods for making L-glufosinate
US-12509709-B2 · Dec 30, 2025 · US
US2025163390A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2025163390-A1 |
| Application number | US-202318840224-A |
| Country | US |
| Kind code | A1 |
| Filing date | Sep 12, 2023 |
| Priority date | Dec 5, 2022 |
| Publication date | May 22, 2025 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A D-amino acid oxidase mutant with significantly improved catalytic performance, a gene encoding the gene, a vector containing the gene, a genetically engineered bacterium, and the application of the said mutant in the microbial catalytic preparation of L-ammonium glufosinate. The D-amino acid oxidase mutant was obtained from the amino acid shown in SEQ ID NO.1 by single-point mutation or multi-point combined mutation. The beneficial effects are mainly reflected in the following: the D-amino acid oxidase mutant with improved enzyme activity and thermal stability can be used in the microbial catalysed preparation of L-ammonium glufosinate, which is conducive to industrial production and has a better application prospect.
Opening claim text (preview).
What is claimed is: 1 . A D-amino acid oxidase mutant, wherein the D-amino acid oxidase mutant is obtained by carrying out single-point mutation or multi-point combined mutation at positions 54, 58, 213, 239, 73, 77, 79, 147, 185, 43, 45, 206, 207, 215, 122, 132, 195, and 234 of an amino acid sequence as shown in SEQ ID NO. 1. 2 . The D-amino acid oxidase mutant according to claim 1 , wherein the D-amino acid oxidase mutant comprises one of the following mutations: (1) mutation of an amino acid residue N at the position 54 to V, D or T, mutation of an amino acid residue F at the position 58 to H, R, K or Q, and mutation of an amino acid residue M at the position 213 to S, N or R; (2) mutation of the amino acid residue N at the position 54 to V, D or T, mutation of the amino acid residue F at the position 58 to H, R, K or Q, mutation of the amino acid residue M at the position 213 to S, N or R, and mutation of an amino acid residue L at the position 239 to E, D, G or Q; (3) mutation of the amino acid residue N at the position 54 to V, D or T, mutation of the amino acid residue F at the position 58 to H, R, K or Q, mutation of the amino acid residue M at the position 213 to S, N or R, mutation of the amino acid residue L at the position 239 to E, D, G or Q, mutation of an amino acid residue A at the position 73 to L, mutation of an amino acid residue Q at the position 77 to W, mutation of an amino acid residue V at the position 79 to M, mutation of an amino acid residue Q at the position 147 to M, and mutation of an amino acid residue S at the position 185 to M; (4) mutation of the amino acid residue N at the position 54 to V, D or T, mutation of the amino acid residue F at the position 58 to H, R, K or Q, mutation of the amino acid residue M at the position 213 to S, N or R, mutation of the amino acid residue L at the position 239 to E, D, G or Q, mutation of an amino acid residue A at the position 43 to S, mutation of an amino acid residue T at the position 45 to M, mutation of an amino acid residue S at the position 206 to A, mutation of an amino acid residue D at the position 207 to P, and mutation of an amino acid residue S at the position 215 to F; and (5) mutation of the amino acid residue N at the position 54 to V, D or T, mutation of the amino acid residue F at the position 58 to H, R, K or Q, mutation of the amino acid residue M at the position 213 to S, N or R, mutation of the amino acid residue L at position 239 to E, D, G or Q, mutation of an amino acid residue E at the position 122 to P, mutation of an amino acid residue Y at the position 132 to F, mutation of an amino acid residue E at the position 195 to Y, and mutation of an amino acid residue C at the position 234 to L. 3 . The D-amino acid oxidase mutant according to claim 2 , wherein an amino acid sequence of the mutant is shown in one of SEQ ID NO. 2 to SEQ ID NO. 7. 4 . A gene encoding the D-amino acid oxidase mutant according to claim 1 . 5 . A recombinant vector containing the gene encoding the D-amino acid oxidase mutant according to claim 1 . 6 . Genetically engineered bacteria containing the gene encoding the D-amino acid oxidase mutant according to claim 1 . 7 . An application of the D-amino acid oxidase mutant according to claim 1 in preparation of L-phosphinothricin through microbial catalysis.
D-Amino acid oxidase (1.4.3.3) · CPC title
D-Amino-acid oxidase (1.4.3.3) · CPC title
Alpha- or beta- amino acids {(other amino acids C12P13/005)} · CPC title
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change · CPC title
Escherichia coli · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.